Table 1. Clinical characteristics of CAH patients: Blood glucose monitored vs unmonitored.
| Blood glucose monitored | Blood glucose not monitored | |
|---|---|---|
| Children with CAH | 6 | 14 |
| Females | 2 | 6 |
| Males | 4 | 8 |
| Mean Age (years ± std dev) | 6.2 ± 2 | 6.2 ± 2.5 |
| Severe type of CAH (salt wasters) | 5 | 11 |
| Receiving flutamide/testolactone treatment | 0 | 7 |
| Hydrocortisone (mg/m2/day ± std dev) | 13.2 ± 2.7 | 10.5 ± 4.5 |
| Fludrocortisone (ug/day ± std dev) | 67 ± 20 | 117± 37 |
| Illness episodes | 8 | 32 |
| IM Solu-Cortef® | 0 | 9 |
| Recent serum metanephrine (pg/mL ± std dev) | 17.8 ± 12.5 | 17.3 ± 9.2 |
| History of hospitalization/ER visit(s) for adrenal crisis | 5 | 9 |